Sponsor Licence for Biotech and Pharma Start-ups: Step-by-Step Hiring Guide

Share

For an early-stage biotech or pharmaceutical company, access to international scientific talent can be critical. The UK has a strong life sciences sector, but finding the right researcher, scientist or technical specialist does not necessarily mean finding someone who already has the right to work in the UK.

For many start-ups, the answer is a sponsor licence.

The difficulty is that applying for a sponsor licence as a young life sciences company is not quite the same as applying as an established corporate employer. A pre-revenue biotech business may have limited trading history, a small workforce and substantial expenditure on research and development rather than conventional commercial activity.

That does not prevent the business from obtaining a licence. However, the company needs to demonstrate clearly that it is a genuine UK organisation and that its proposed recruitment is credible.

This guide explains the key issues for founders and operations teams considering a sponsor licence for a biotech or pharma start-up, including eligibility, supporting evidence, the application process, Certificates of Sponsorship, salary requirements and ongoing compliance.

Eligibility: proving you are a genuine organisation

What UKVI considers a genuine organisation

Before granting a sponsor licence, UK Visas and Immigration (UKVI) must be satisfied that the organisation is operating lawfully in the UK and that it has a genuine need to sponsor workers.

This can create particular challenges for an early-stage life sciences business.

A company may have only a handful of employees, little or no revenue and a relatively short trading history. However, that does not mean it cannot demonstrate genuine business activity. The important issue is whether the evidence creates a coherent picture of a real business operating in the UK.

For a biotech start-up, useful evidence can include:

  • a certificate of incorporation and Companies House records;
  • a UK business bank account;
  • employer's liability insurance;
  • evidence of office or laboratory premises;
  • contracts and commercial agreements;
  • invoices and expenditure;
  • correspondence with customers, suppliers or research partners;
  • investor funding and investment documentation;
  • evidence of recruitment;
  • business plans and financial forecasts; and
  • evidence of the company's research and development programme.

UKVI may also conduct a pre-licence visit. The business should therefore be able to explain what it does, where it operates and why it needs sponsored workers.

Evidencing R&D activity and grant funding

Life sciences companies have an important advantage when building this evidence: genuine commercial activity does not necessarily mean substantial revenue.

A pre-revenue biotech company may be spending significant amounts on laboratory research, clinical development, intellectual property and specialist personnel while generating little or no income.

Evidence of this activity can be particularly valuable. Depending on the business, it could include:

  • Innovate UK or UKRI grant awards;
  • clinical trial registrations;
  • patent applications or filings;
  • published research;
  • agreements with universities or NHS trusts;
  • research collaborations;
  • investor funding;
  • laboratory leases or co-working laboratory agreements; and
  • regulatory approvals or applications.

The objective is not to demonstrate that the company has reached a particular revenue threshold. It is to demonstrate that there is a genuine R&D business operating in the UK and a credible reason for the proposed sponsored roles.

For a biotech start-up, the strongest application will usually connect the evidence together: the company has been established in the UK, it has funding or investment, it has identifiable research activity, it has premises or arrangements from which that activity is conducted, and it has a genuine need for the international expertise it is seeking to recruit.

The sponsor licence application process

Once the business has established that it can evidence a genuine organisation and a genuine need for sponsorship, it can begin the sponsor licence application.

Key personnel: Authorising Officer, Key Contact and Level 1 User

The sponsor licence requires the business to nominate its key personnel: the Authorising Officer, Key Contact and Level 1 User.

In a small biotech company, it is common for one or two individuals to hold several of these roles.

The Authorising Officer should ideally be someone who understands both the business and its research programme. For example, a founder or senior director may be particularly well placed to explain why the company needs to recruit a particular scientist and how that person's work fits into the company's R&D programme.

Academic founders should not assume that academic work undertaken outside the UK automatically creates a problem. However, relevant employment and other circumstances must be disclosed where required and the nominated key personnel must satisfy the relevant suitability requirements.

For a detailed explanation of the roles and the wider sponsor compliance framework, see our sponsor compliance guidance.

Supporting documents for biotech and pharma applicants

The precise evidence required will depend on the circumstances of the business, but applications commonly require documents such as:

  • certificate of incorporation;
  • VAT registration, where applicable;
  • employer's liability insurance;
  • recent audited or unaudited accounts, where available; and
  • evidence of business activity.

For a pre-revenue biotech start-up, alternative evidence can be particularly important. Grant award letters, investor documentation, regulatory approvals and evidence of laboratory or office premises may help demonstrate that the company is genuinely operating and has a credible business purpose.

As of November 2026, the fee for a Worker sponsor licence is £611 for a small or charitable sponsor and £1,682 for a medium or large sponsor. A business is generally considered a small sponsor where at least two of the relevant size criteria apply, including turnover of no more than £15 million, total assets of no more than £7.5 million, or 50 employees or fewer.

Standard sponsor licence applications can take several weeks. A priority service is available for eligible applications for an additional £750, with the application considered within 10 working days, although priority processing does not guarantee that the licence will be granted.

Assigning Certificates of Sponsorship

Obtaining the sponsor licence is only the beginning. Once the licence is granted, the business must obtain and assign a Certificate of Sponsorship (CoS) before the worker can apply for their Skilled Worker visa.

Defined and undefined CoS

The distinction is important for start-ups planning their recruitment pipeline.

A Defined CoS is generally required where a worker is applying for Skilled Worker entry clearance from outside the UK.

An Undefined CoS is generally used for Skilled Workers applying from within the UK, including workers switching into the Skilled Worker route where permitted.

Defined CoS requests are made through the Sponsorship Management System (SMS), and the Home Office states that these applications are usually approved within one working day.

A new sponsor will normally receive an initial CoS allocation. As the business grows, it can request additional allocation where it can demonstrate a genuine need.

For a start-up, this means immigration planning needs to sit alongside the recruitment plan. If the company knows that it expects to recruit several scientists from overseas during a particular funding or development phase, it should consider the timing of its licence application, CoS allocation and individual visa applications rather than treating each recruitment as an isolated exercise.

Setting salaries and occupation codes for research roles

Choosing the correct SOC 2020 occupation code is particularly important in life sciences because the occupation code determines the relevant Skilled Worker salary framework.

Some potentially relevant codes include:

SOC 2020 code Occupation Current going rate*
2111 Chemical scientists £39,900
2112 Biological scientists £40,300
2119 Natural and social science professionals not elsewhere classified £41,500
2217 Medical radiographers NHS pay scale
3111 Laboratory technicians £33,400

*Going rates for the relevant occupations are generally based on a 37.5-hour working week and must be pro-rated where appropriate. Healthcare occupations such as 2217 follow the applicable national pay framework rather than the standard Table 1 going-rate structure.

The current standard Skilled Worker salary requirement is generally the higher of £41,700 or the applicable going rate, although a number of salary options and reductions can apply depending on the worker's circumstances.

This is particularly relevant to biotech companies recruiting researchers.

A qualifying applicant may potentially benefit from the salary reductions for:

  • a relevant PhD;
  • a relevant STEM PhD;
  • a qualifying new entrant; or
  • a qualifying postdoctoral position.

For example, the current rules allow the new entrant option to apply where the worker is under 26 or where the role is a qualifying postdoctoral position in specified scientific SOC codes, including 2111, 2112, 2113, 2114, 2115 and 2119.

The general salary and occupation-specific requirements still need to be satisfied, so a reduced percentage of the going rate does not mean that an employer can simply choose a lower salary.

Example: a Series A biotech recruiting a postdoctoral computational biologist

Imagine a Series A biotech company has identified a postdoctoral computational biologist in the US.

The business needs to establish:

  1. the most appropriate SOC 2020 occupation code based on the actual duties;
  2. whether the role qualifies as a postdoctoral position;
  3. whether the applicant holds the relevant PhD;
  4. whether another salary option applies;
  5. the applicable going rate;
  6. the worker's contracted weekly hours; and
  7. whether the salary meets both the applicable general salary threshold and occupation-specific requirement.

The key point is that the job title alone does not determine the immigration treatment. The sponsor needs to assess the actual role, duties, qualifications and salary before assigning the CoS.

For a broader explanation of the Skilled Worker salary framework, see our article on [Skilled Worker salary thresholds].

What about ATAS?

ATAS is another issue that life sciences employers should consider early, but it is important not to assume that every biotech or pharmaceutical researcher needs ATAS clearance.

Under the current rules, the requirement depends on factors including the sponsor's status, the worker's nationality, the occupation and whether the role involves the relevant PhD-level research in an ATAS-listed subject. The Home Office guidance confirms that ATAS applications can take at least 20 working days and may take 30 or more working days between April and September.

Where ATAS does apply, the timing can therefore become a material part of the recruitment process.

The sponsor should determine whether ATAS applies before assigning the CoS, rather than discovering the requirement after the candidate has been recruited.

Compliance duties from day one

Once the sponsor licence is granted, the company takes on ongoing sponsor duties. These include maintaining appropriate records, monitoring sponsored workers and reporting relevant changes to UKVI. See our detailed guide to sponsor compliance for the full checklist.

Life sciences businesses should also consider compliance issues arising from the way research is actually conducted.

For example, a scientist may spend part of their week at the sponsor's own laboratory and part at a university or research partner's premises. The sponsor needs to understand whether a change in work location or working arrangements creates a reporting obligation under the sponsor guidance.

Similarly, a pharma company moving from pre-clinical research into a clinical trial programme may experience a substantial change in its business activities. If UKVI conducts a compliance visit, the company should be able to explain how the sponsored workers' roles relate to the current research and development programme.

Sponsors should also be prepared for compliance visits. New sponsors can receive visits relatively early in the life of the licence, so records should be maintained continuously rather than assembled only when an inspection is expected.

Where laboratory technicians or other staff are supplied through an agency or other intermediary, the business should also consider whether the arrangement creates additional right-to-work or sponsorship obligations as the relevant rules develop.

The safest approach is to treat immigration compliance as part of the company's operational infrastructure from the beginning rather than as an administrative exercise that starts when UKVI announces a visit.

Growing your sponsored workforce

A sponsor licence should be designed around the company's expected growth, not just its first hire.

Adding CoS allocations as you scale

As the business recruits more international workers, it can request additional CoS allocation through the Sponsor Management System.

UKVI will consider whether the additional allocation is justified, including the company's growth, compliance history and genuine recruitment requirements.

For a biotech company that has just raised a funding round, for example, the evidence supporting an allocation request may include the new funding, updated recruitment plans, new contracts, expansion of laboratory operations and details of the roles the business expects to fill.

Preparing for UKVI compliance visits

New sponsors should assume that their licence may be scrutinised.

This is particularly important when the business is growing rapidly. A company that obtained its licence with three employees may look very different six or twelve months later.

Keep HR and immigration records organised and accessible, including:

  • right-to-work evidence;
  • employment contracts;
  • salary records;
  • absence records;
  • job descriptions;
  • CoS information;
  • changes to personal details;
  • records of work locations; and
  • evidence of compliance with sponsor duties.

A poor compliance outcome can put the sponsor licence itself at risk, including through downgrade, suspension or revocation.

Consider the wider immigration strategy

As the business grows, Skilled Worker sponsorship should not necessarily remain the only immigration route under consideration.

For founders, the Innovator Founder visa may provide an alternative where the individual meets the route's requirements and does not already have settled status. It is based on endorsement and does not require the founder's own company to sponsor them.

For senior researchers, the Global Talent route may be particularly valuable.

The UK has significantly expanded the Global Talent endorsed-funder pathway in 2026. More than 100 R&D-intensive businesses have been added to the group of organisations able to host eligible researchers, including businesses in life sciences and other high-growth sectors.

The route can allow eligible researchers to work without being sponsored under the Skilled Worker system. However, the requirements are specific. For the UKRI fast-track pathway, for example, the applicant must be hosted or employed by a UKRI-approved organisation and make a critical contribution to research supported by a qualifying grant or award from an endorsed funder. The grant generally needs to be worth at least £30,000 and cover at least two years.

This can be particularly relevant to research-intensive biotech and pharmaceutical companies. The current UKRI list includes commercial research organisations, and the government has announced further expansion of the pathway.

For a life sciences business with a significant research programme, it is therefore worth considering whether the company could make use of Global Talent alongside Skilled Worker sponsorship rather than defaulting to sponsorship for every international researcher.

FAQs

Can a pre-revenue biotech start-up get a sponsor licence?

Yes. There is no requirement for a biotech company to have substantial revenue before it can apply.

However, the company needs to demonstrate that it is a genuine organisation operating lawfully in the UK and that it has a genuine need for the workers it proposes to sponsor.

Evidence of funding, R&D activity, laboratory premises, research partnerships, intellectual property and recruitment plans can be particularly useful.

What evidence does UKVI accept instead of financial accounts for start-ups?

The appropriate evidence depends on the circumstances of the business. For a pre-revenue company, this might include grant funding, investor documentation, contracts, regulatory material, evidence of laboratory or office premises and other documents demonstrating genuine business activity.

The important issue is the overall picture rather than one particular document.

How long does a sponsor licence application take?

Standard processing can take several weeks. Eligible applicants can request priority processing for an additional £750, with applications considered within 10 working days. Priority processing does not guarantee approval.

How many Certificates of Sponsorship will I receive as a new licence holder?

The initial allocation depends on the circumstances of the sponsor. If the business needs additional CoS, it can make a request through the Sponsorship Management System and explain its recruitment requirements.

What happens if UKVI visits my start-up shortly after granting the licence?

UKVI may inspect the business and its systems. The company should be able to demonstrate that it is operating as described in the sponsor licence application and that it understands and is complying with its sponsor duties.

The best preparation is therefore ongoing compliance rather than attempting to prepare for a visit at short notice.

Can I sponsor researchers on the Global Talent visa instead of Skilled Worker?

Global Talent is not a form of employer sponsorship in the same way as Skilled Worker.

However, eligible research-intensive organisations can now act as UKRI-approved host or employing organisations for the relevant Global Talent endorsed-funder pathway. Eligible researchers can therefore potentially work without the employer holding a Skilled Worker sponsor licence for them.

The worker and organisation must satisfy the specific Global Talent requirements.

What is the cost of a sponsor licence for a small company?

As of November 2026, the Worker sponsor licence fee for a small or charitable sponsor is £611. The fee for a medium or large sponsor is £1,682.

Other costs can apply when sponsoring workers, including Certificate of Sponsorship fees, the Immigration Skills Charge where applicable and visa-related costs.

Conclusion: plan your sponsor licence around your hiring timeline

For a biotech or pharmaceutical start-up, obtaining a sponsor licence should form part of the company's recruitment and growth strategy rather than being treated as a standalone immigration application.

The strongest applications usually begin with the evidence: demonstrate genuine UK operations, establish the company's R&D activity, document its funding and premises, and explain why international recruitment is necessary.

The business should then identify the appropriate occupation codes and salary options before recruiting, plan its CoS requirements and consider whether routes such as Global Talent could complement Skilled Worker sponsorship.

Finally, compliance needs to be built into the company's processes from day one.

For founders who expect to recruit internationally as their research programme develops, getting the sponsor licence structure right early can make subsequent hiring considerably more straightforward.

Ready to apply for a sponsor licence for your biotech or pharma start-up? Our employer immigration team can guide you through the application and help you build a compliant hiring process from the start.

BOOK AN APPOINTMENT

Have a question?

For a no-obligation expert opinion, get in touch. 

Complete the form below and we'll be in touch as soon as possible.